The global targeted protein degradation market was valued at USD 138.25 million in 2024 and is expected to reach USD 300.70 million by 2032. During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 10.20%, primarily driven by the rising demand for novel therapeutics and increasing investment in drug discovery technologies.
AiraBreeze is a compact personal cooling device designed to provide refreshing airflow in...
Glucotex est un complément alimentaire formulé pour aider à maintenir une glycémie saine,...